Tag: approves

Amgen’s small cell lung cancer treatment receives FDA approval

The Food and Drug Administration recently approved Amgen’s therapy for patients with the most deadly form of lung cancer. The drug, to be marketed as Imdelltra, is intended for use as a second or later line of treatment for individuals with advanced small-cell lung cancer. Clinical trials have shown that the drug can reduce tumor […]

Back To Top